Quantcast

Latest pharmaceutical industry Stories

2014-07-09 16:28:10

Study calls for more focus on long-term outcomes in pediatric trials of drugs intended for chronic use BOSTON, July 9, 2014 /PRNewswire-USNewswire/ -- Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events, researchers at Boston Children's Hospital report today in PLOS...

2014-07-08 23:10:01

GIA announces the release of a comprehensive global report on Pharmaceutical Contract Manufacturing markets. Global market for Pharmaceutical Contract Manufacturing is forecast to reach US$23.4 million by 2020, spurred by pricing pressures and shrinking margins aggravated by patent expiries, regulatory and competitive pressures, and emergence of generics to replace blockbuster drugs nearing patent expiries. San Jose, California (PRWEB) July 08, 2014 Global pharmaceutical contract...

2014-07-08 23:08:34

Great Point Partners announces a growth recapitalization of Softbox Systems, Ltd. (“Softbox”), a leading provider of temperature controlled packaging (“TCP”) solutions for the biotechnology and pharmaceutical industries. GREENWICH, CT (PRWEB) July 08, 2014 Great Point Partners, a Greenwich-based health care investment firm, today announced a growth recapitalization of Softbox Systems, Ltd. (“Softbox”). Softbox is a leading provider of temperature controlled packaging...

2014-07-08 23:08:23

ReportsnReports.com adds “PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market” to its store. Lucrative Biosimilars Space to Erode Biologics Market from 2019. Dallas, Texas (PRWEB) July 08, 2014 The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking the overall biologics market value from $162 billion in...

2014-07-08 23:03:02

PharmacyChecker.com published almost 2000 consumer comments showing that Americans are concerned about new federal regulations expanding the authority of the FDA to destroy safe drug imports for personal use. PharmacyChecker.com submitted public comments to the FDA, offering suggestions that would protect access by Americans to safe and affordable prescription drugs. White Plains, NY (PRWEB) July 08, 2014 PharmacyChecker.com announced the publication on its website of almost 2000 comments...

2014-07-08 23:01:29

Good Manufacturing Practices in Pharmaceutical and Biotech fields goes a long way in saving millions of lives worldwide in providing safe and affordable therapeutic solutions to various dreadful diseases. OMICS Group’s 3rd International Summit on GMP, GCP & Quality Control, held on September 25-26, 2014, in Valencia, Spain attains significance at this juncture as it is going to address many valid points. Los Angeles, CA (PRWEB) July 08, 2014 GMP Summit -2014 is going to discuss...

2014-07-08 16:25:34

DUBLIN, July 8, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Dalfampridine Extended-release Tablets, 10 mg. Actavis' ANDA product is a generic version of Acorda Therapeutics' Ampyra(®), which is indicated as a treatment to improve walking in patients with multiple sclerosis. Acorda Therapeutics, Inc. filed suit against Actavis on...

2014-07-08 08:30:07

PITTSBURGH, July 8, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Telmisartan Tablets USP, 20 mg, 40 mg and 80 mg, the generic version of Boehringer Ingelheim's Micardis® Tablets. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment of hypertension, to lower blood pressure. Telmisartan Tablets USP, 20 mg, 40 mg and 80...

2014-07-07 12:29:12

- Designation supports the advancement of CTL019 to help address the unmet need of patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL) EAST HANOVER, N.J., July 7, 2014 /PRNewswire/ -- Novartis announced today that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic...

2014-07-07 08:28:53

BEIJING, July 7, 2014 /PRNewswire/ -- Yabao Pharmaceutical Co, Inc. (Shanghai Stock Exchange 600351), a leading pharmaceutical company in China, today announced a strategic partnership with Eli Lilly and Company to co-develop Lilly's leading glucokinase activator (GKA), LY2608204. Lilly's GKA has completed Phase 1 studies in the US in addition to extensive pre-clinical development. Diabetes is a disease of great unmet need in China and worldwide. Glucokinase activators have the...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related